首页> 美国卫生研究院文献>Drugs in Context >Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management
【2h】

Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management

机译:婴幼儿多灶性肝血管瘤合并肝受累2例及治疗对策

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Infantile haemangiomas (IHs) are the most common benign tumours of childhood; despite the benign histology, prognosis depends on severity of visceral involvement, with a mortality rate ranging from 50 to 90%. In this paper, we describe two infants with multifocal infantile haemangiomatosis and hepatic involvement. This condition should receive appropriate management as it can be potentially lethal due to the high risk of systemic complications such as cardiac or fulminant hepatic failure and abdominal compartment syndrome. Both cases presented with liver involvement, but only the infant who had an excellent response to propranolol is still alive. A review of current therapeutic approaches is also presented even though there are, at present, no uniform guidelines for treatment, despite the relative frequency of infantile haemangiomatosis and the potential severe complications.
机译:婴儿性血管瘤(IHs)是儿童期最常见的良性肿瘤。尽管组织学良好,但预后取决于内脏受累的严重程度,死亡率为50%至90%。在本文中,我们描述了两名患有多灶性婴儿血管瘤病和肝脏受累的婴儿。由于全身性并发症(如心脏或暴发性肝功能衰竭和腹腔室综合征)的高风险可能会致死,因此应适当治疗。这两个病例均表现为肝脏受累,但只有对普萘洛尔反应良好的婴儿仍活着。尽管目前尚无统一的治疗指南,但尽管婴儿期血管瘤病的发生频率相对较高且可能存在严重的并发症,但仍对当前的治疗方法进行了综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号